Skip to main content

Advertisement

Table 1 Baseline data at the start of dialysis

From: Higher mortality of patients on haemodialysis with pancreatic diabetes compared to type 2-diabetes

  Pancreatic diabetes Type 2 diabetes
  (n = 12) (n = 84)
Age (years) 56 ± 6* 63 ± 8*
Sex (female %) 50% 52%
Diabetes duration (years) 17 ± 7 18 ± 6
HbA1c (%) 7.5 ± 1.3 7.6 ± 1.1
Body weight (kg) 59 ± 7** 70 ± 11**
BMI (kg/m2) 22 ± 3* 25 ± 4*
C-peptide basal (ng/ml) 0.9 ± 0.3* 1.9 ± 0.6*
Systolic blood pressure (mm Hg) 136 ± 12 137 ± 10
Diastolic blood pressure (mm Hg) 86 ± 9 87 ± 8
Antidiabetic therapy (%)   
Diet and sulfonylurea 0 5%
Conventional insulin therapy 50% 44%
Intensified insulin therapy 50% 41%
Insulin dose (IU/day) 22+11* 32+11*
Vascular access (n/%)   
Arteriovenous fistula 10 (83%) 64 (76%)
Permcath-dialysis catheter 2 (17/%) 20 (24%)
Insulin dose (IU/day) 22 ± 11* 32 ± 16*
Duration of dialysis (hours//week) 13 (12-15) 13 (12-15)
Kt/V (three month after start of HD) 1.3 1.4
  1. p < 0.05, **p < 0.01. Data are expressed as x+SD, x (range) or %